SpeakerDr Susan Welsh
Conference Chair
19 to 20 May 2027 · London, UK
The room where drug safety moves forward.
The 17th Annual Pharmacovigilance Europe Congress brings senior decision-makers together to share knowledge, shape the future and drive better patient outcomes.
Watch the highlights1,800+
Attendees
250+
Speakers
100+
Exhibitors
17
Years
The people who make progress happen
Here’s who is attending
Senior decision-makers from 40+ countries across the drug safety community.
MHRA
AstraZeneca
Johnson & Johnson
Bristol Myers Squibb
Sanofi
Novartis
Roche
Pfizer
One room, every perspective
Bringing the entire community together
Make the most of your time
One conference, many ways to connect
Choose the experience that fits your goals, whether you are here to learn, exhibit, speak or build new partnerships.
Conference Passes
Access inspiring sessions, expert panels and industry insights.
ExploreExhibition Booths
Showcase your solutions, meet qualified leads and build lasting partnerships.
ExploreSponsorship Packages
Increase your visibility, position your brand and achieve your business goals.
ExploreNetworking Sessions
Connect with peers, build relationships and explore new opportunities.
ExploreSpeaker Panels
Hear from global experts and gain practical insights for what is next.
ExplorePartner Meetings
Arrange one-to-one meetings and find the right partners for your goals.
ExploreThe opportunity ahead
A growing field needs better conversations
As the global pharmacovigilance market grows, the people responsible for patient safety need trusted spaces to share what works.
US$10bn
Global market in 2024
US$13.5bn
Projected by 2030
5.1%
Expected CAGR
17
years of the congress
20+
international pioneers
40+
countries represented
10+ hrs
of dedicated networking
The people shaping the conversation
Meet the 2027 speakers
Speaker
SpeakerAlison Cave
Chief Safety Officer, MHRA
SpeakerAmrit Gill
VP, Global Head of Pharmacovigilance, Opella
SpeakerJean-Marc C. Haeusler
Global Head, International Patient Safety, Roche
SpeakerCalvin Johnson
Head of International Patient Safety, Bristol Myers Squibb
SpeakerMichael Bean
Senior Director, Regulatory Compliance, Johnson & Johnson
Built for the people doing the work
Who should attend
Meet senior professionals and decision-makers across the life-sciences community, from pharma and biotech to CROs and solution providers.
Pharmaceutical and biopharmaceutical leaders
Biotech, CRO and medical diagnostics teams
Clinical trials, R&D and clinical pharmacology specialists
Pharmacovigilance and drug safety professionals
Regulatory affairs and risk management teams
Life-sciences solution providers and consultants
Be part of the room
Sponsors and exhibitors
Put your organisation in front of the people making decisions across pharmacovigilance, safety and regulatory affairs.
Platinum
Roche
AstraZeneca
Johnson & Johnson
Gold
Bristol Myers Squibb
Genentech
Opella
Exhibitor
CSL
Kyowa Kirin
MHRA
The value of being there
The conversations are the event.
Meet the right people and take the next conversation home.
“Build useful relationships with decision-makers from more than 40 countries.”
Why delegates attend
Focused, useful networking.
“Ten or more hours of dedicated networking make it easier to meet peers facing similar challenges.”
Delegate experience
More than a programme
Why attend Pharmacovigilance Europe?
01
Share practical insight
Hear how senior teams are handling the decisions that shape modern drug safety.
02
Meet the right people
Build useful relationships with decision-makers from more than 40 countries.
03
Stay close to the field
Bring current thinking on signal management, inspections and risk management back to your team.
04
Create new opportunities
Use focused sessions, exhibitions and partner meetings to move conversations forward.
London · 19 to 20 May 2027
Join us in London
Join the world’s leading pharmacovigilance gathering and make two days count.
Register NowMake two days count.